PET ORIENTED INTENSIFICATION AND MAINTENANCE WITH RITUXIMAB IN FIRST LINE NON‐HODGKIN LARGE B CELL LYMPHOMA (DLBCL)

Authors :: L. Mettivier
G. Cassiordor
L Pezzullo
R. Guariglia
C. Martorelli
S. Luponio
R Fontana
Bianca Serio
I Ferrara
Carmine Selleri
R Rosamilio
Source :: Hematological Oncology. 39
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Cancer Research
Oncology
business.industry
First line
Cancer research
medicine
Rituximab
Hematology
General Medicine
B-cell lymphoma
medicine.disease
business
medicine.drug

Tools